Johnson Chen is the Founder & CEO of global private capital raising platform CapBridge, which together with its associate entity 1exchange, one of Singapore’s first regulated private securities exchange, form a comprehensive private markets capital eco-system for growth companies and sophisticated investors.
CapBridge holds a Capital Markets Services License and 1exchange holds a Recognised Market Operator License. Both entities are regulated by the Monetary Authority of Singapore (MAS), and Singapore Exchange (SGX) is a strategic partner and shareholder. The entities work in close consultation with MAS and SGX to continually uplift the capital market in Singapore.
An active angel investor and experienced business builder, Johnson has spent over 20 years incubating and steering growth companies in Singapore and Hong Kong.
Johnson has founded and listed two companies on SGX. He is the Founder and Non-executive Chairman of Clearbridge Health (SGX ticker: 1H3, Bloomberg ticker: CBH.SP), a pan-Asia precision healthcare company. Johnson is also the Founder and Non-executive Director of Biolidics (SGX) ticker: 88Y, Bloomberg ticker: BLD.SP), a microfluidic based liquid biopsy tumor diagnosis company. Earlier in his career, Johnson co-founded and successfully exited two tech start-ups.
He was one of the pioneering team members of Hong Kong-based information and communications technology service company Pacific Century CyberWorks Limited (PCCW). He was subsequently appointed President of CyberWorks Ventures, PCCW’s direct investment arm where he led a team to build up and oversee a multi-million dollar investment portfolio. The youngest member of PCCW’s M&A/investment executive committee at that time, he was responsible for much of PCCW’s strategic
expansion, including many of its successful acquisitions and investments.
Johnson sits on the Singapore National Research Foundation Proof-of-Concept grant panel and is a member of the Strategic Research Innovation Fund committee of NTUitive, Nanyang Technological University’s innovation and enterprise company.
He is a member of the Singapore A*STAR A*ccelerate Liquid Biopsy Program Advisory Committee, where he advises on the development trajectory of the agency’s liquid biopsy programme.
As the top graduate in the officer cadet course during his National Service with the Singapore Armed Forces, Johnson was awarded the prestigious Sword of Honour by the President of Singapore.
Johnson holds a Master’s degree and a Bachelor degree in Manufacturing Engineering Tripos (MET) from the University of Cambridge, UK.